Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Holding 0.35.

<< Previous

Bullboard Posts

Next >>

Comment by 2b7f6fabon Nov 01, 2024 3:57pm

183 Views

Post# 36292939

RE:RE:Holding 0.35.

Beano349 wrote: 0.25, my by on the typo

I don't see any expiring soon. Footnote 9 to the financials shows the warrants and when they expire. In June 30, 2023 and September 7, 2023 there were $0.35 two year warrants issued. And November 29, 2023 $0.28 five year warrants issued.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec